These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


672 related items for PubMed ID: 34696483

  • 41. Hepatitis B seroconversion revisited: new insights into the natural history of acute hepatitis B virus (HBV) infection from quantitative and highly sensitive assays and novel biomarkers.
    Kuhns MC, Holzmayer V, McNamara AL, Anderson M, Cloherty GA.
    Virol J; 2021 Nov 29; 18(1):235. PubMed ID: 34844619
    [Abstract] [Full Text] [Related]

  • 42. Occult hepatitis B virus infection in anti-HBs-positive infants born to HBsAg-positive mothers in China.
    Su H, Zhang Y, Xu D, Wang B, Zhang L, Li D, Xiao D, Li F, Zhang J, Yan Y.
    PLoS One; 2013 Nov 29; 8(8):e70768. PubMed ID: 23951004
    [Abstract] [Full Text] [Related]

  • 43. Low Prevalence of Anti-HBc Antibody and Lack of HBV DNA Among HBsAg-Negative Blood Donors in Iran: A Cross-sectional Study and Review of Literature.
    Hedayati-Moghaddam MR, Tehranian F, Mosavat A, Miri R, Ahmadi Ghezeldasht S.
    Arch Iran Med; 2024 Jun 01; 27(6):305-312. PubMed ID: 38855800
    [Abstract] [Full Text] [Related]

  • 44. A mathematical approach to estimate the efficacy of individual-donation and minipool nucleic acid amplification test options in preventing transmission risk by window period and occult hepatitis B virus infections.
    Vermeulen M, van Drimmelen H, Coleman C, Mitchel J, Reddy R, Lelie N.
    Transfusion; 2014 Oct 01; 54(10):2496-504. PubMed ID: 24749834
    [Abstract] [Full Text] [Related]

  • 45. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India.
    Keechilot CS, Shenoy V, Kumar A, Biswas L, Vijayrajratnam S, Dinesh K, Nair P.
    Pathog Glob Health; 2016 Oct 01; 110(7-8):287-291. PubMed ID: 27788631
    [Abstract] [Full Text] [Related]

  • 46. Hepatitis B virus genotype, HBsAg mutations and co-infection with HCV in occult HBV infection.
    Arababadi MK, Pourfathollah AA, Jafarzadeh A, Hassanshahi G, Salehi M, Ahmadabadi BN, Kennedy D.
    Clin Res Hepatol Gastroenterol; 2011 Sep 01; 35(8-9):554-9. PubMed ID: 21835725
    [Abstract] [Full Text] [Related]

  • 47. Occult hepatitis B infection among blood donors from Yaoundé, Cameroon.
    Fopa D, Candotti D, Tagny CT, Doux C, Mbanya D, Murphy EL, Kenawy HI, El Chenawi F, Laperche S.
    Blood Transfus; 2019 Nov 01; 17(6):403-408. PubMed ID: 31846605
    [Abstract] [Full Text] [Related]

  • 48. Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy.
    Coffin CS, Mulrooney-Cousins PM, Osiowy C, van der Meer F, Nishikawa S, Michalak TI, van Marle G, Gill MJ.
    J Clin Virol; 2014 Aug 01; 60(4):347-53. PubMed ID: 24881491
    [Abstract] [Full Text] [Related]

  • 49. Characterization of occult hepatitis B virus infection from blood donors in China.
    Zheng X, Ye X, Zhang L, Wang W, Shuai L, Wang A, Zeng J, Candotti D, Allain JP, Li C.
    J Clin Microbiol; 2011 May 01; 49(5):1730-7. PubMed ID: 21411575
    [Abstract] [Full Text] [Related]

  • 50. Hepatitis B virus DNA in unusual serological profiles of hepatitis B surface antigen-positive sera.
    Chongsrisawat V, Thawornsuk N, Theamboonlers A, Louisirirotchanakul S, Poovorawan Y.
    Viral Immunol; 2006 May 01; 19(4):623-9. PubMed ID: 17201657
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Occult hepatitis B virus infection in Greek patients with congenital bleeding disorders.
    Varaklioti A, Kouramba A, Ioannidou P, Katsarou O.
    Infect Genet Evol; 2017 Oct 01; 54():397-401. PubMed ID: 28705716
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Drug-resistant and immune-escape hepatitis B virus mutants, occult hepatitis B infection and coinfections in public hospital patients from Argentina.
    Delfino CM, Giorgio M, García G, Puch SS, Outon E, Mathet VL.
    Virus Genes; 2021 Aug 01; 57(4):327-337. PubMed ID: 34091827
    [Abstract] [Full Text] [Related]

  • 55. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.
    Gutiérrez C, Devesa M, Loureiro CL, León G, Liprandi F, Pujol FH.
    J Med Virol; 2004 Jun 01; 73(2):200-7. PubMed ID: 15122793
    [Abstract] [Full Text] [Related]

  • 56. Antigenicity reduction contributes mostly to poor detectability of HBsAg by hepatitis B virus (HBV) S-gene mutants isolated from individuals with occult HBV infection.
    Zhang K, Liu Y, Chen R, Li Q, Xu Z, Si L, Cheng Y, Yang Y, Chen J, Xu D, Lin S.
    J Med Virol; 2018 Feb 01; 90(2):263-270. PubMed ID: 28876463
    [Abstract] [Full Text] [Related]

  • 57. Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing.
    Lelie N, Bruhn R, Busch M, Vermeulen M, Tsoi WC, Kleinman S, International NAT Study Group.
    Transfusion; 2017 Jan 01; 57(1):24-35. PubMed ID: 27673757
    [Abstract] [Full Text] [Related]

  • 58. [Analysis of hepatitis B virus (HBV) preS1, preS2 and S gene regions from patient groups infected with HBV genotype D].
    Karataş E, Erensoy S, Akarca US, Sertöz R.
    Mikrobiyol Bul; 2018 Jan 01; 52(1):23-34. PubMed ID: 29642827
    [Abstract] [Full Text] [Related]

  • 59. Occult Hepatitis B Virus Infection in Maintenance Hemodialysis Patients: Prevalence and Mutations in "a" Determinant.
    Tang Y, Liu X, Lu X, He Q, Li G, Zou Y.
    Int J Med Sci; 2020 Jan 01; 17(15):2299-2305. PubMed ID: 32922195
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 34.